I reported previously (9th July) that Ben Gurion University Professor Varda Shoshan-Barmatz had discovered that suppressing the protein VDAC1 inhibits tumor growth. Her team’s latest research shows that small interfering ribonucleic acids (siRNAs) can reprogram the cancer cells back to normal-like cells.  Ointment for pre-skin cancer is in Phase 2 trials. http://in.bgu.ac.il/en/bgn/pages/news/cancer.aspx

https://www.timesofisrael.com/israel-researchers-say-they-have-found-way-to-curb-growth-of-cancer-cells/

http://www.vidacpharma.com/index.php/news/78-vidac-pharma-reports-positive-results-from-phase-2a-proof-of-concept-trial-of-vda-1102-ointment-in-actinic-keratosis